Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 1;174(9):823-824.
doi: 10.1001/jamapediatrics.2020.1884.

Providing Contraception for Young People During a Pandemic Is Essential Health Care

Tracey A Wilkinson  1 , Melissa J Kottke  2 , Elise D Berlan  3
Affiliations
Review

Providing Contraception for Young People During a Pandemic Is Essential Health Care

Tracey A Wilkinson et al. JAMA Pediatr. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Drs. Wilkinson and Kottke have no conflicts of interest to disclose. Dr. Berlan is a consultant to Merck and Bayer and is a Nexplanon Clinical Trainer.

Figures

Figure 1:
Figure 1:. Algorithm for Providing Contraception for Young People During a Pandemic
Abbreviations: AYA=Adolescents and Young Adults, HCP=Health Care Professional, US MEC= US Medical Eligibility Criteria for Contraceptive Use, BP=Blood Pressure, DMPA: Depot Medroxyprogesterone Acetate, LARC=Long-Acting Reversible Contraception, EC=Emergency Contraception
See this image and copyright information in PMC

Comment in

References

    1. Curtis KM TN, Jatlaoui TC, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. 2016. - PubMed
    1. www.bedsider.org. Accessed April 4, 2020.
    1. Quick Start Algorithm-Patient requests a new birth control method. 2019; https://www.reproductiveaccess.org/wp-content/uploads/2014/12/Quickstart....
    1. Depo-Provera Sub-Q User Guide. 2017; https://www.reproductiveaccess.org/resource/depo-subq-user-guide/. Accessed April 2, 2020.
    1. McNicholas C, Swor E, Wan L, Peipert JF. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration. Am J Obstet Gynecol. 2017;216(6):586.e581–586.e586. - PMC - PubMed